Search Within

Gregory J Riely

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (8)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (31)
  2. Genitourinary Oncology Service (31)
  3. Solid Tumor Oncology Division (31)
  4. Thoracic Oncology (31)
  5. GSK Faculty (29)
  6. Human Oncology and Pathogenesis Program (29)

More Groups

People
  1. David Solit (29)
  2. Marc Ladanyi (22)
  3. Michael Berger (22)
  4. Charles Rudin (16)
  5. Maria Arcila (15)
  6. Bob Li (14)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Clinical Cancer Research (4)
  3. Cancer Discovery (3)
  4. Nature Medicine (3)
  5. JCO Precision Oncology (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. American Association for Cancer Research (7)
  3. Nature Publishing Group (6)
  4. Cell Press (2)
  5. American Medical Association (1)
  6. Oxford University Press (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MAPK pathway alterations correlate with poor survival and drive resistance to therapy in patients with lung cancers driven by ROS1 fusions
    Journal Article

    Sato, H.; Schoenfeld, A. J.; Siau, E.; Lu, Y. C.; Tai, H.; Suzawa, K.; Kubota, D.; Lui, A. J. W.; Qeriqi, B.; Mattar, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
    Journal Article

    Razavi, P.; Li, B. T.; Brown, D. N.; Jung, B.; Hubbell, E.; Shen, R.; Abida, W.; Juluru, K.; De Bruijn, I.; Hou, C.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Frequency and outcomes of brain metastases in patients with HER2-mutant lung cancers
    Journal Article

    Offin, M.; Feldman, D.; Ni, A.; Myers, M. L.; Lai, W. V.; Pentsova, E.; Boire, A.; Daras, M.; Jordan, E. J.; Solit, D. B.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: Results from the Actionable Genome Consortium
    Journal Article

    Li, B. T.; Janku, F.; Jung, B.; Hou, C.; Madwani, K.; Alden, R.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Isbell, J. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent alterations in EGFR-mutant lung cancers associated with resistance to EGFR kinase inhibitors and characterization of MTOR as a mediator of resistance
    Journal Article

    Yu, H. A.; Suzawa, K.; Jordan, E.; Zehir, A.; Ni, A.; Kim, R.; Kris, M. G.; Hellmann, M. D.; Li, B. T.; Somwar, R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save